Publication: Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.
dc.contributor.author | Rosado-Sánchez, I | |
dc.contributor.author | Herrero-Fernández, I | |
dc.contributor.author | Genebat, M | |
dc.contributor.author | Ruiz-Mateos, E | |
dc.contributor.author | Leal, M | |
dc.contributor.author | Pacheco, Yolanda M | |
dc.date.accessioned | 2023-01-25T09:42:39Z | |
dc.date.available | 2023-01-25T09:42:39Z | |
dc.date.issued | 2016-10-20 | |
dc.description.abstract | The persistence of an inverted CD4/CD8 ratio has been extensively associated with the increased morbimortality of chronic human immunodeficiency virus (HIV)-infected subjects. Thymic function is crucial for the maintenance of T cell homeostasis. We explored the impact of thymic function on the CD4/CD8 ratio of HIV-infected subjects. In a cohort of 53 antiretroviral-naive HIV-infected subjects, the measure of thymic volume, as a representative marker for thymic function, was available at baseline and at 12, 24, and 48 weeks post antiretroviral treatment. Baseline thymic volume was associated with the CD4/CD8 ratio ( Ρ: = 0.413, P = .002), being this association highly dependent on the CD4 T cell levels. In subjects who achieved undetectable viral load after treatment (n = 33), a higher baseline thymic volume was associated with a higher increase in CD4 T cell counts and a decreasing trend in CD8 T cell counts during follow-up. Moreover, the baseline thymic volume was independently associated with the normalization of the CD4/CD8 ratio after 96 weeks of treatment (odds ratio, 95% confidence interval: 1.95 (1.07-3.55); P = .03). Our data indicate the relevance of the remaining thymic function before the start of treatment to the CD4/CD8 ratio of HIV- infected subjects and, hence, potentially, in their clinical progression. | |
dc.identifier.doi | 10.1093/cid/ciw711 | |
dc.identifier.essn | 1537-6591 | |
dc.identifier.pmid | 27986677 | |
dc.identifier.unpaywallURL | https://academic.oup.com/cid/article-pdf/64/2/152/13803513/ciw711.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/10690 | |
dc.issue.number | 2 | |
dc.journal.title | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | |
dc.journal.titleabbreviation | Clin Infect Dis | |
dc.language.iso | en | |
dc.organization | Instituto de Biomedicina de Sevilla-IBIS | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 152-158 | |
dc.pubmedtype | Journal Article | |
dc.rights.accessRights | open access | |
dc.subject | CD4/CD8 ratio | |
dc.subject | HIV | |
dc.subject | antiretroviral naive. | |
dc.subject | delta-TRECs | |
dc.subject | thymic function | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Antiretroviral Therapy, Highly Active | |
dc.subject.mesh | Biomarkers | |
dc.subject.mesh | CD4 Lymphocyte Count | |
dc.subject.mesh | CD4-CD8 Ratio | |
dc.subject.mesh | Female | |
dc.subject.mesh | HIV Infections | |
dc.subject.mesh | HIV-1 | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Immunophenotyping | |
dc.subject.mesh | Male | |
dc.subject.mesh | Organ Size | |
dc.subject.mesh | Phenotype | |
dc.subject.mesh | T-Lymphocyte Subsets | |
dc.subject.mesh | Thymus Gland | |
dc.subject.mesh | Tomography, X-Ray Computed | |
dc.subject.mesh | Treatment Outcome | |
dc.subject.mesh | Viral Load | |
dc.title | Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 64 | |
dspace.entity.type | Publication |